Media Thread, page-5431

First 5431 Last

Share
Profile

Follow
mmc4

307 Posts.

171

15/05/22

19:56

Post #: 61419954
Share

Originally posted by fourdollars: ↑

Thanks i83atu.

Interesting isn't it.

You believe IMU was only ever going to proceed with different combination trials of HER-Vaxx. If this were correct then you're saying it only did the current HER-Vaxx trial for its own benefit (ie to convince itself that its worth proceeding with trials like nextHERIZON, neoHERIZON, neuHERIZON). The FDA has approved nextHERIZON without final HER-Vaxx results - so it's approval must be based on earlier trial results. There's also the question as to why it took more than a year to announce these combination trials since apparently starting these trials wasn't being held up by final O/S results.

I believe that IMU bought HER-Vaxx with the intention of it replacing Herceptin (which would have required it to proceed to Phase 3 in combination with chemo - ie Phase 3 of the current Phase 2 as opposed to the now-planned combination trials), but changed its mind after the interim results (without making this explicit).

@davybabyk and @Owl vs Fox and others believe that they will be proceeding with Phase 3 HER-Vaxx and that the only thing holding this up is the final O/S results from HER-Vaxx Phase 2. In this camp, the likelihood of Phase 3 has only gotten stronger over the past year since "the longer the trial goes, the better".

Obviously you and the @davybabyk camp can't both be right.

What particularly annoys me about management is the fact that we have to guess. Intelligent people who have all been long term holders and are fairly well across the announcements, with such divergent views.

Why can't management just make it explicit? There is no commercial-in-confidence issue as 1) HER-Vaxx is patented and 2) its just announcing the planned progress of a treatment that is in the public domain.

Good luck with your investment.

Expand

I agree with @fourdollars,that with so many clearly intelligent investors in Imugene, that there remains a definite divergence of opinion between SH. Whether this be the time between announcements, or detail in announcements, there does appear to be an opportunity for management to reduce the speculation, by lifting the level of communications a tad. I love LC, and believe her to be an absolute blessing to IMU, I just want clarity, to help strengthen the next SP growth trend, which I believe will commence this week coming and beyond!

Last edited by mmc4: 15/05/22

IMU Price at posting: 17.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

Shekel Brainweigh and Calmer Co lead innovations in the retail space

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

There are more pages in this discussion • 9,237 more messages in this thread...

First 5431 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.7¢		Change -0.002(3.39%)		Mkt cap ! $418.9M

Open	High	Low	Value	Volume
6.0¢	6.2¢	5.6¢	$1.863M	31.44M

Buyers (Bids)

No.	Vol.	Price($)
3	214965	5.7¢

Sellers (Offers)

Price($)	Vol.	No.
5.8¢	60000	1

View Market Depth

No.	Vol.	Price($)
3	214965	0.057
14	1550875	0.056
26	4138021	0.055
9	1730287	0.054
4	131036	0.053

Price($)	Vol.	No.
0.058	60000	1
0.059	708216	4
0.060	1196314	8
0.061	471000	3
0.062	236412	6

Last trade - 16.10pm 15/07/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-5431

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-5431

Top Stories

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News